Novonesis (Novozymes) B (FRA:NZM) E10: €1.55 (As of Mar. 2026)


FRA:NZM Novonesis (Novozymes) B FRA:NZM
88 GF Score
Price €53.50
GF Value €55.23
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B E10?

Novonesis (Novozymes) B FRA:NZM +0.94% 88 E10 is €1.55 as of Mar. 2026. GuruFocus rates FRA:NZM with a GF Score™ of 88/100 and a GF Value™ of €55.23 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.55 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Novonesis (Novozymes) B's average E10 Growth Rate was -0.60% per year. During the past 3 years, the average E10 Growth Rate was 0.50% per year. During the past 5 years, the average E10 Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novonesis (Novozymes) B was 9.60% per year. The lowest was 0.50% per year. And the median was 7.35% per year.

As of today (2026-06-30), Novonesis (Novozymes) B's current stock price is €53.50. Novonesis (Novozymes) B's E10 for the quarter that ended in Mar. 2026 was €1.55. Novonesis (Novozymes) B's Shiller PE Ratio of today is 34.52.

During the past 13 years, the highest Shiller PE Ratio of Novonesis (Novozymes) B was 54.32. The lowest was 24.11. And the median was 38.77.


Novonesis (Novozymes) B  (FRA:NZM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novonesis (Novozymes) B's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=53.50/1.55
=34.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Novonesis (Novozymes) B was 54.32. The lowest was 24.11. And the median was 38.77.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novonesis (Novozymes) B E10 Related Terms


Novonesis (Novozymes) B E10 Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B E10 Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.50 1.55 1.52 1.51

Novonesis (Novozymes) B Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.57 1.49 1.51 1.55

FRA:NZM vs LIN, SHW, ECL: E10 Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B Shiller PE Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Shiller PE Ratio falls into.


FRA:NZM
88GF Score
Novonesis (Novozymes) B FRA:NZM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis (Novozymes) B's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.43/121.2000*121.2000
=0.430

Current CPI (Mar. 2026) = 121.2000.

Novonesis (Novozymes) B Quarterly Data

per share eps CPI Adj_EPS
201606 0.331 100.600 0.399
201609 0.333 100.200 0.403
201612 0.363 100.300 0.439
201703 0.347 101.200 0.416
201706 0.332 101.200 0.398
201709 0.372 101.800 0.443
201712 0.356 101.300 0.426
201803 0.366 101.700 0.436
201806 0.356 102.300 0.422
201809 0.370 102.400 0.438
201812 0.386 102.100 0.458
201903 0.323 102.900 0.380
201906 0.418 102.900 0.492
201909 0.299 102.900 0.352
201912 0.434 102.900 0.511
202003 0.386 103.300 0.453
202006 0.306 103.200 0.359
202009 0.340 103.500 0.398
202012 0.314 103.400 0.368
202103 0.424 104.300 0.493
202106 0.381 105.000 0.440
202109 0.405 105.800 0.464
202112 0.301 106.600 0.342
202203 0.401 109.900 0.442
202206 0.390 113.600 0.416
202209 0.557 116.400 0.580
202212 0.424 115.900 0.443
202303 0.379 117.300 0.392
202306 0.293 116.400 0.305
202309 0.451 117.400 0.466
202312 0.339 116.700 0.352
202403 0.080 118.400 0.082
202406 0.060 118.500 0.061
202409 0.340 118.900 0.347
202412 0.190 118.900 0.194
202503 0.400 120.200 0.403
202506 0.290 120.700 0.291
202509 0.300 121.600 0.299
202512 0.260 121.200 0.260
202603 0.430 121.200 0.430

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.55 mean?
Novonesis (Novozymes) B (FRA:NZM) has a E10 of €1.55 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's E10 too high?
Novonesis (Novozymes) B's current E10 is €1.55. Overall, Novonesis (Novozymes) B has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's E10 compare to LIN and SHW?
Novonesis (Novozymes) B's E10 of €1.55 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Chemicals company?
A good E10 depends on the Chemicals industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current E10 is €1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Based on GuruFocus' analysis, Novonesis (Novozymes) B (FRA:NZM) is currently considered Fairly Valued. The stock's GF Value™ is €55.23, compared to a current price of €53.50 — trading 3.1% below its estimated fair value. The current E10 is €1.55. Novonesis (Novozymes) B's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Novonesis (Novozymes) B (FRA:NZM), the current E10 is €1.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (FRA:NZM) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of €53.50 is trading 3.1% below its estimated GF Value™ of €55.23. GuruFocus considers Novonesis (Novozymes) B to be Fairly Valued.

Key valuation signals for FRA:NZM:

  • E10: €1.55
  • GF Value™: €55.23 vs. price of €53.50 (3.1% below fair value)
  • GF Score™: 88/100 with 3 warning signs

No single metric tells the full story. See the FRA:NZM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
88GF Score

Get the complete analysis for FRA:NZM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€53.50
Price
€55.23
GF Value